Chemoembolization in India

Treatment Cost of Chemoembolization in India

The cost of transarterial chemoembolization (TACE) in India is significantly lower compared to countries like the USA, UK, or Australia, while maintaining high standards of care and advanced technology.

Average Cost:

₹1,50,000 to ₹3,50,000 per TACE session

Key Cost Factors:

Type of Hospital: Corporate hospitals charge more than government or trust-run facilities.

City of Treatment: Metropolitan cities like Delhi, Mumbai, and Bangalore have higher costs due to advanced infrastructure.

Number of Sessions: Some patients may need more than one session depending on their medical condition.

Oncologist & Radiologist Fees: Highly experienced specialists may charge premium consultation and procedure fees.

Additional Tests: Imaging (CT/MRI), liver function tests, and follow-up checkups add to the total cost.

Hospital Stay: Includes room charges, nursing care, and medicines post-procedure.

Despite the variation, India offers world-class TACE treatment at affordable prices, making it a preferred destination for international patients seeking quality cancer care on a budget.

Top Cities in India for TACE (Transarterial Chemoembolization)

India is a hub for advanced cancer treatment, with many cities offering cutting-edge TACE procedures led by highly qualified doctors and supported by modern healthcare infrastructure.

1. Delhi NCR

Hospitals: Medanta, Fortis, AIIMS, Max Super Specialty

Strengths: Experienced oncologists, global accreditations (NABH, JCI)

2. Mumbai

Hospitals: Tata Memorial Hospital, Kokilaben Dhirubhai Ambani Hospital, Lilavati Hospital

Strengths: Premier oncology centers, high patient success rates

3. Bangalore

Hospitals: HCG Cancer Centre, Manipal Hospital, Apollo Bangalore

Strengths: State-of-the-art interventional radiology units

4. Chennai

Hospitals: MIOT International, Apollo Hospitals, Fortis Malar

Strengths: Comprehensive cancer care with multidisciplinary teams

5. Hyderabad

Hospitals: Yashoda Hospitals, AIG Hospitals, Apollo Hyderabad

Strengths: Affordable packages for international patients

These cities are known for their robust infrastructure, skilled professionals, and international patient services, making them ideal for undergoing transarterial chemoembolization in India.

More Info About TACE (Transarterial Chemoembolization)

TACE is a localized treatment strategy that offers a significant advantage over systemic therapies in specific cancer cases. Here's more in-depth information about how it works and what to expect:

Procedure Overview:

Pre-procedure Evaluation: Blood tests, liver function tests, CT/MRI scans

During the Procedure:

• Local anesthesia and sedation are administered.
• A catheter is inserted through the groin into the hepatic artery.
• Chemotherapy drugs are injected directly into the blood vessels feeding the tumor.
• Embolic agents are introduced to block the artery and trap the drug inside the tumor.

Duration: 1 to 2 hours

Hospital Stay: Typically 1–2 days

Benefits of TACE:

• High concentration of chemotherapy to the tumor
• Minimal impact on healthy tissues
• Slows tumor progression
• Can be repeated multiple times
• Serves as a pre-operative bridge to surgery or transplantation

Risks and Side Effects:

• Nausea, vomiting, fever, fatigue (Post-Embolization Syndrome)
• Temporary liver function changes
• Infection or bleeding at the catheter site
• Rarely, damage to healthy liver tissue

Follow-Up:

Post-TACE follow-up includes blood tests and imaging (CT or MRI) to monitor tumor response. Patients are advised to avoid strenuous activities for a few days and maintain a healthy liver-friendly diet.

Others – When is Chemoembolization Recommended?

Chemoembolization is not suitable for all patients. It is recommended based on individual medical profiles, tumor characteristics, and liver function.

Indications for TACE:

• Primary liver cancer (Hepatocellular carcinoma)
• Secondary liver tumors (e.g., metastases from colon, breast, or neuroendocrine tumors)
• Patients ineligible for surgery due to poor liver reserve or comorbidities
• Patients awaiting liver transplant (TACE used as a bridge therapy)
• Tumors that are localized and not involving major liver blood vessels

Contraindications:

• Advanced liver cirrhosis
• Complete blockage of the portal vein
• Poor overall health or renal dysfunction
• Allergy to contrast dyes used in imaging

TACE is often part of a multimodal treatment plan, used alongside systemic therapies or immunotherapy depending on cancer staging and progression.